Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iridex Corp (NQ: IRIX )

1.690 -0.080 (-4.52%)
Streaming Delayed Price Updated: 3:59 PM EST, Nov 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Iridex Corp

< Previous 1 2 Next >
Iridex Reports Third Quarter 2024 Financial Results
From IRIDEX Corporation
Via GlobeNewswire
Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024
From IRIDEX Corporation
Via GlobeNewswire
Iridex Appoints Patrick Mercer as Chief Executive Officer
From IRIDEX Corporation
Via GlobeNewswire
IRIDEX Corp. (NASDAQ: IRIX) Records 52-Week High Tuesday Morning
Via Investor Brand Network
Iridex Reports Second Quarter 2024 Financial Results
From IRIDEX Corporation
Via GlobeNewswire
Iridex Announces Convertible Note Financing
From IRIDEX Corporation
Via GlobeNewswire
Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024
From IRIDEX Corporation
Via GlobeNewswire
Iridex Reports First Quarter 2024 Financial Results
From IRIDEX Corporation
Via GlobeNewswire
Iridex to Report First Quarter 2024 Financial Results on May 14, 2024
From IRIDEX Corporation
Via GlobeNewswire
Iridex Reports Fourth Quarter and Full Year 2023 Financial Results
Advances strategic review to unlock shareholder value 
From IRIDEX Corporation
Via GlobeNewswire
Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024
From IRIDEX Corporation
Via GlobeNewswire
Iridex Corporation Receives European Patent on MicroPulse Technology
The Advanced Short Pulse Laser System 
From IRIDEX Corporation
Via GlobeNewswire
Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust
From IRIDEX Corporation
Via GlobeNewswire
Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma
From IRIDEX Corporation
Via GlobeNewswire
Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation
Action Retains Full Patient Access to MicroPulse® Transscleral Laser Treatment 
From IRIDEX Corporation
Via GlobeNewswire
Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation
From IRIDEX Corporation
Via GlobeNewswire
Iridex Reports Third Quarter 2023 Financial Results and Business Update
From IRIDEX Corporation
Via GlobeNewswire
Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023
The Company also announced plans to present at Stifel Healthcare Conference 
From IRIDEX Corporation
Via GlobeNewswire
Iridex to Report Third Quarter Financial Results on November 14, 2023
From IRIDEX Corporation
Via GlobeNewswire
Iridex Announces Strategic Review to Unlock Shareholder Value
From IRIDEX Corporation
Via GlobeNewswire
Iridex Reports Second Quarter 2023 Financial Results
From IRIDEX Corporation
Via GlobeNewswire
Iridex to Report Second Quarter Financial Results on August 10, 2023
From IRIDEX Corporation
Via GlobeNewswire
Iridex Reports First Quarter 2023 Financial Results
From IRIDEX Corporation
Via GlobeNewswire
Iridex to Report First Quarter Financial Results on May 11, 2023
From IRIDEX Corporation
Via GlobeNewswire
Iridex Reports Fourth Quarter and Full Year 2022 Financial Results
Achieves Record Quarterly Glaucoma Probe Sales and 6% Full Year Revenue Growth 
From IRIDEX Corporation
Via GlobeNewswire
Iridex to Present at the 35th Annual Roth Conference
From IRIDEX Corporation
Via GlobeNewswire
Iridex Introduces New Research and Showcases Five Events at the AGS Meeting
From IRIDEX Corporation
Via GlobeNewswire
Iridex to Report Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023
From IRIDEX Corporation
Via GlobeNewswire
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2022
Achieves Record Quarterly Glaucoma Probe sales and 6% Full Year Revenue Growth 
From IRIDEX Corporation
Via GlobeNewswire
Iridex to Participate in Fireside Chat with Stifel Equity Research
From IRIDEX Corporation
Via GlobeNewswire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.